Medical Treatment of Neuroendocrine Tumors

This publication has 29 references indexed in Scilit:

• Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
  Journal of Clinical Oncology, 2008
• Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group
  Journal of Clinical Oncology, 2003
• Prospective study of the antitumor efficacy of long‐term octreotide treatment in patients with progressive metastatic gastrinoma
  Cancer, 2002
• Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.
  Gut, 1996
• An Update of the Medical Treatment of Malignant Endocrine Pancreatic Tumors
  Acta Oncologica, 1993
• Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours
  European Journal of Cancer, 1992
• Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma
  New England Journal of Medicine, 1992
• Metastatic carcinoid and islet cell tumours of the pancreas: A phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin
  European Journal of Cancer and Clinical Oncology, 1991
• A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A southwest oncology group study
  Cancer, 1987
• Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma
  New England Journal of Medicine, 1980